Livzon Pharmaceutical Group Inc.’s Net Profit Dropped 5.3% in First Half of 2022

Livzon Pharmaceutical Group Inc. (丽珠医药集团股份有限公司) (000513.SZ) reported a net profit of 1.1 billion yuan in the first half of 2022, down 5.3% year-on-year.

Meanwhile, the company posted 6.3 billion yuan in revenue, up 1.1% year-on-year.

At the end of the reporting period, it had 22.9 billion yuan in total assets and 9 billion yuan in total liabilities, with a liability-to-asset ratio of 39%.